• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病发生的危险因素。

Risk factors for the development of chronic obstructive pulmonary disease.

作者信息

Silverman E K, Speizer F E

机构信息

Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Med Clin North Am. 1996 May;80(3):501-22. doi: 10.1016/s0025-7125(05)70451-x.

DOI:10.1016/s0025-7125(05)70451-x
PMID:8637301
Abstract

Cigarette smoking clearly has been shown to be the major environmental risk factor predisposing to the development of COPD. Occupational exposures to dust and fumes, air pollution, passive smoke exposure, childhood respiratory infections, and diet may also contribute. Airway hyperresponsiveness is a risk factor for the development of decline in FEV1, but its role in the development of COPD remains uncertain. Alpha1-antitrypsin deficiency is an important genetic risk factor for COPD in the small minority of COPD patients who inherit this deficiency. Other genetic factors are likely involved but have not yet been identified. Elucidation of additional genetic risk factors may provide useful insights into the pathogenesis of COPD. Potential interactions between the various environmental and genetic risk factors may be extremely important in determining the variable development of COPD.

摘要

吸烟显然已被证明是导致慢性阻塞性肺疾病(COPD)发生的主要环境风险因素。职业性接触粉尘和烟雾、空气污染、被动吸烟、儿童期呼吸道感染以及饮食也可能起作用。气道高反应性是第一秒用力呼气容积(FEV1)下降的一个风险因素,但其在COPD发生中的作用仍不确定。α1-抗胰蛋白酶缺乏是少数遗传性COPD患者发生COPD的一个重要遗传风险因素。可能还涉及其他遗传因素,但尚未得到确认。阐明更多的遗传风险因素可能为COPD的发病机制提供有用的见解。各种环境和遗传风险因素之间的潜在相互作用在决定COPD的不同发展过程中可能极其重要。

相似文献

1
Risk factors for the development of chronic obstructive pulmonary disease.慢性阻塞性肺疾病发生的危险因素。
Med Clin North Am. 1996 May;80(3):501-22. doi: 10.1016/s0025-7125(05)70451-x.
2
The pathogenesis of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的发病机制。
Am J Med Sci. 1999 Aug;318(2):74-8. doi: 10.1097/00000441-199908000-00002.
3
[The environmental risk factors for COPD--tobacco smoke, air pollution, chemicals].[慢性阻塞性肺疾病的环境危险因素——烟草烟雾、空气污染、化学物质]
Nihon Rinsho. 2003 Dec;61(12):2101-6.
4
Genetic and environmental modulation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的遗传与环境调控
Respir Physiol. 2001 Oct;128(1):3-11. doi: 10.1016/s0034-5687(01)00258-4.
5
Effects of air pollution and smoking on chronic obstructive pulmonary disease and bronchial asthma.空气污染和吸烟对慢性阻塞性肺疾病及支气管哮喘的影响。
Tohoku J Exp Med. 1998 Nov;186(3):151-67. doi: 10.1620/tjem.186.151.
6
[Genetic risk factors for chronic obstructive pulmonary disease (COPD)].[慢性阻塞性肺疾病(COPD)的遗传风险因素]
Nihon Rinsho. 1999 Sep;57(9):1954-8.
7
[Risk factors of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病的危险因素]
Ann Ist Super Sanita. 2003;39(4):485-93.
8
Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.重度早发性慢性阻塞性肺疾病的遗传流行病学。亲属患气流阻塞和慢性支气管炎的风险。
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1770-8. doi: 10.1164/ajrccm.157.6.9706014.
9
[Homozygous alpha 1-antitrypsin deficiency. Lung changes in children and adolescents].[纯合子α1-抗胰蛋白酶缺乏症。儿童和青少年的肺部变化]
Monatsschr Kinderheilkd. 1993 May;141(5):395-400.
10
The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.烟雾暴露对爱尔兰α-1抗胰蛋白酶缺乏症临床表型的影响:利用国家登记系统了解一种罕见疾病。
COPD. 2015 May;12 Suppl 1:2-9. doi: 10.3109/15412555.2015.1021913.

引用本文的文献

1
Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study.急性加重及其表型对住院慢性阻塞性肺疾病患者临床结局的影响:一项横断面研究
Toxics. 2022 Nov 6;10(11):667. doi: 10.3390/toxics10110667.
2
Assessment of pulmonary functions among traffic police personnel in Chennai city - A comparative cross-sectional study.钦奈市交警人员肺功能评估——一项比较性横断面研究。
J Family Med Prim Care. 2020 Jul 30;9(7):3356-3360. doi: 10.4103/jfmpc.jfmpc_1126_19. eCollection 2020 Jul.
3
The Th17/Treg Cytokine Imbalance in Chronic Obstructive Pulmonary Disease Exacerbation in an Animal Model of Cigarette Smoke Exposure and Lipopolysaccharide Challenge Association.
香烟暴露和脂多糖刺激的动物模型中慢性阻塞性肺疾病加重期的 Th17/Treg 细胞细胞因子失衡及其关联。
Sci Rep. 2019 Feb 13;9(1):1921. doi: 10.1038/s41598-019-38600-z.
4
Measuring the Prevalence of Diagnosed Chronic Obstructive Pulmonary Disease in the United States Using Data From the 2012-2014 National Health Interview Survey.利用2012 - 2014年美国国家健康访谈调查数据测量美国已诊断慢性阻塞性肺疾病的患病率。
Public Health Rep. 2017 Mar/Apr;132(2):149-156. doi: 10.1177/0033354916688197. Epub 2017 Jan 30.
5
Targeted high-throughput sequencing of candidate genes for chronic obstructive pulmonary disease.慢性阻塞性肺疾病候选基因的靶向高通量测序
BMC Pulm Med. 2016 Nov 11;16(1):146. doi: 10.1186/s12890-016-0309-y.
6
Childhood maltreatment as a risk factor for COPD: findings from a population-based survey of Canadian adults.儿童期受虐作为慢性阻塞性肺疾病的一个风险因素:基于加拿大成年人的一项人口调查结果
Int J Chron Obstruct Pulmon Dis. 2016 Oct 26;11:2641-2650. doi: 10.2147/COPD.S107549. eCollection 2016.
7
Association of IREB2 Gene rs2568494 Polymorphism with Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.IREB2基因rs2568494多态性与慢性阻塞性肺疾病风险的关联:一项荟萃分析
Med Sci Monit. 2016 Jan 18;22:177-82. doi: 10.12659/msm.894524.
8
Early chronic obstructive pulmonary disease: definition, assessment, and prevention.早期慢性阻塞性肺疾病:定义、评估与预防
Lancet. 2015 May 2;385(9979):1778-1788. doi: 10.1016/S0140-6736(15)60647-X.
9
Common genetic determinants of lung function, subclinical atherosclerosis and risk of coronary artery disease.肺功能、亚临床动脉粥样硬化和冠状动脉疾病风险的常见遗传决定因素。
PLoS One. 2014 Aug 5;9(8):e104082. doi: 10.1371/journal.pone.0104082. eCollection 2014.
10
The involvement of phospholipases A2 in asthma and chronic obstructive pulmonary disease.磷脂酶 A2 在哮喘和慢性阻塞性肺疾病中的作用。
Mediators Inflamm. 2013;2013:793505. doi: 10.1155/2013/793505. Epub 2013 May 13.